Thermo Fisher Scientific是科學服務領域的世界領導者,我們的使命是幫助客戶使世界更健康、更潔淨、更安全。無論客戶的需求是加速生命科學研究、解決複雜的分析難題、提高實驗室生產力,或是透過診斷或突破性療法改善患者的健康狀況,我們都能提供支持。我們的全球團隊透過領先同業的品牌為客戶提供創新技術、購買便利和全方位的服務:Thermo Scientific、Applied Biosystems、Invitrogen、Fisher Scientific、Unity Lab Services、Patheon 和 PPD。
欲了解更多資訊,請瀏覽公司網站:www.thermofisher.com
產品簡介:
Gibco™ CTS™ Rotea Counterflow Centrifugation System
The CTS Rotea Counterflow Centrifugation instrument, single-use kit, and CTS Rotea software work together seamlessly to provide a closed cell processing system. The CTS Rotea instrument is compact and versatile and integrates smoothly at multiple points in your workflow. The single-use kit includes all tubing and the rotating centrifuge chamber. Compatible with Luer connectors and sterile welding to the fluid containers, the gamma-irradiated kits help to ensure a closed system. Finally, the CTS Rotea software runs on an adjacent tablet computer, allowing you to view and modify protocols and visually monitor the process in real time.
Gibco™ CTS™ Xenon Electroporation System
The CTS Xenon Electroporation System offers reliable delivery of DNA, RNA, proteins, and other molecules into cells, with exceptional cell viability and recovery. This leads to efficient transfection and genome editing, even in hard-to-transfect cells. A choice of two single-use electroporation chambers of different capacities provides flexibility: the SingleShot chamber enables process development while the MultiShot cartridge can be used in a closed, commercial-scale transfection system that minimizes contamination and human error while maximizing safety.
Gibco™ CTS™ DynaCellect Magnetic Separation System
The CTS DynaCellect Magnetic Separation System is a closed, automated isolation, activation, and bead removal system for cell therapy development and manufacturing. Together with fit-for-purpose consumables, it delivers high cell purity, recovery, and viability. As a standalone instrument or as part of a workflow, the operator-independent system will help you isolate the right cells and minimize failures in manufacturing while helping provide increased robustness and precision.
2021 | Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center |
2021 | Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society |
2021 | Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China |
2021 | Thermo Fisher Scientific Launches First T-Cell Medium Designed Specifically for Allogeneic Cell Therapy Workflows |
2020 | Thermo Fisher Scientific and Lyell Immunopharma Form Cell Therapy Manufacturing Partnership |
2017 | Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership |